Concepedia

Todd J. Friends

TJ

6

Publications

154

Citations

6

H-Index

2004

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Karo Pharma (Sweden)

Todd J. Friends is an author at Bristol-Myers Squibb (United States) specializing in drug discovery, medicine, and pharmacology.

Top concepts

Publications per year

2004–2019

6

Publications

6

Thyroid receptor ligands. Part 2: Thyromimetics with improved selectivity for the thyroid hormone receptor beta

Jon J. Hangeland, Arthur M. Doweyko, Tamara Dejneka et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 52 citations · Full text

, , +10

Phenylimidazoles as Potent and Selective Inhibitors of Coagulation Factor XIa with in Vivo Antithrombotic Activity

Jon J. Hangeland, Todd J. Friends, Karen A. Rossi et al. · Journal of Medicinal Chemistry · 2014 · 38 citations · Full text

, , +22

Pyridine and pyridinone-based factor XIa inhibitors

James R. Corte, Tianan Fang, Jon J. Hangeland et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 20 citations · Full text

, , +4

Design and SAR of selective T-type calcium channel antagonists containing a biaryl sulfonamide core

Jon J. Hangeland, Daniel L. Cheney, Todd J. Friends et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 15 citations · Full text

, , +3

Discovery of Potent Protease-Activated Receptor 4 Antagonists with in Vivo Antithrombotic Efficacy

Michael M. Miller, Jacques Banville, Todd J. Friends et al. · Journal of Medicinal Chemistry · 2019 · 15 citations · Full text

Rows per page

1–5 of 6